Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Equity Ratio: 2018-2019

Historic Equity Ratio for DiaMedica Therapeutics (DMAC) over the last 1 years, with Sep 2019 value amounting to 0.88.

  • DiaMedica Therapeutics' Equity Ratio was N/A to 0.88 in Q3 2019 from the same period last year, while for Sep 2019 it was 0.88, marking a year-over-year change of. This contributed to the annual value of 0.93 for FY2018, which is N/A change from last year.
  • According to the latest figures from Q3 2019, DiaMedica Therapeutics' Equity Ratio is 0.88, which was down 3.91% from 0.91 recorded in Q2 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Equity Ratio peaked at 0.93 during Q4 2018, and registered a low of 0.88 during Q3 2019.
  • For the 2-year period, DiaMedica Therapeutics' Equity Ratio averaged around 0.90, with its median value being 0.91 (2019).